Xiuyan Wang

4.6k total citations · 1 hit paper
23 papers, 877 citations indexed

About

Xiuyan Wang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Xiuyan Wang has authored 23 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Xiuyan Wang's work include CAR-T cell therapy research (8 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Virus-based gene therapy research (2 papers). Xiuyan Wang is often cited by papers focused on CAR-T cell therapy research (8 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Virus-based gene therapy research (2 papers). Xiuyan Wang collaborates with scholars based in China, United States and Australia. Xiuyan Wang's co-authors include Shizheng Li, Kun Li, Qian Zhao, Song Yuan, Isabelle Rivière, Michel Sadelain, Bo Wang, Renier J. Brentjens, Bo Wang and Marco L. Davila and has published in prestigious journals such as Blood, PLoS ONE and Journal of Virology.

In The Last Decade

Xiuyan Wang

23 papers receiving 865 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs

2023 190 citations Ran Qi, Yixuan Bai et al. Drug Resistance Updates profile →

Peers

Countries citing papers authored by Xiuyan Wang

Since Specialization

Citations

This map shows the geographic impact of Xiuyan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuyan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuyan Wang more than expected).

Fields of papers citing papers by Xiuyan Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuyan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuyan Wang. The network helps show where Xiuyan Wang may publish in the future.

Co-authorship network of co-authors of Xiuyan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuyan Wang. A scholar is included among the top collaborators of Xiuyan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuyan Wang. Xiuyan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fluorescence On–Off Response of Hydrogen-Bonded Viologen-Polyoxometalate Supramolecular Structure for the Determination of Ag⁺ in Beverages and Daily Necessities 2025 ·Inorganic Chemistry ·Kai Li, Xiuyan Wang, Jun Ying, (unknown), Aixiang Tian, (unknown), (unknown)	1
2	A Novel Multichromic Cd(II) Coordination Polymer Based on a Viologen Ligand Exhibiting Multichroism, Aniline Detection and Luminescence Properties 2024 ·Russian Journal of Inorganic Chemistry ·(unknown), Xiuyan Wang, Xin Wang, (unknown), (unknown), Hongqiang Wang	2
3	Case report: Robust response to sintilimab in advanced distal cholangiocarcinoma with PD-L1 expression and DNA damage repair 2024 ·Frontiers in Pharmacology ·Wenguang He, Congcong Song, (unknown), Xiao Ji, Xiuyan Wang, Lixia Liu	2
4	Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs breakdown → 2023 ·Drug Resistance Updates ·Ran Qi, Yixuan Bai, Kun Li, Nanbin Liu, (unknown), (unknown), Yufeng Wang, Rui Lin, Hui Wang, Zhongyan Liu, Xinbo Li, Xiuyan Wang, Baomin Shi	190
5	A novel biocontrol agent Bacillus velezensis K01 for management of gray mold caused by Botrytis cinerea 2023 ·AMB Express ·(unknown), Yunge Zhang, Kun Huang, Xiuyan Wang, (unknown), (unknown), Yanbin Guo	8
6	Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells 2022 ·Nature Biomedical Engineering ·Sjoukje J. C. van der Stegen, (unknown), Roseanna M. Petrovic, Hongyao Xie, (unknown), Vera Alexeeva, Yuzhe Shi, Jorge Mansilla‐Soto, Mohamad Hamieh, Justin Eyquem, Annalisa Cabriolu, Xiuyan Wang, Ramzey Abujarour, Tom T. Lee, Raedun Clarke, Bahram Valamehr, Maria Themeli, Isabelle Rivière, Michel Sadelain	49
7	Anesthetic effect of sevoflurane in the craniotomy hematoma evacuation treatment of hypertensive cerebral hemorrhage 2022 ·Panminerva Medica ·(unknown), Xiuyan Wang, (unknown)	2
8	Target Densities in Malignant and Normal Cells Determine CAR T Cell Efficacy and Off-Target Hematotoxicity 2022 ·Blood ·Sascha Haubner, Jorge Mansilla‐Soto, Sarah Nataraj, (unknown), Qing Chang, Elisa de Stanchina, Kathryn Fraser, Jae H. Park, Xiuyan Wang, Isabelle Rivière, Michel Sadelain	2
9	Polydopamine-assisted PDGF-BB immobilization on PLGA fibrous substrate enhances wound healing via regulating anti-inflammatory and cytokine secretion 2020 ·PLoS ONE ·Xiao Yang, (unknown), Xiuyan Wang, Qiushuang Zhang, Yi Zhang, Haitao Fan, Ranwei Li, (unknown)	24
10	Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it 2018 ·Biomedicine & Pharmacotherapy ·Shizheng Li, Song Yuan, Qian Zhao, Bo Wang, Xiuyan Wang, Kun Li	127
11	Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector 2018 ·Molecular Therapy ·Eric L. Smith, Mette Stæhr, Reed Masakayan, (unknown), Terence J. Purdon, Xiuyan Wang, Pei Wang, Hong Liu, Yiyang Xu, Sarah C. Garrett-Thomson, Steven C. Almo, Isabelle Rivière, Liu C, Renier J. Brentjens	76
12	Quercetin reversed MDR in breast cancer cells through down‐regulating P‐gp expression and eliminating cancer stem cells mediated by YB‐1 nuclear translocation 2018 ·Phytotherapy Research ·Shizheng Li, Qian Zhao, Bo Wang, Song Yuan, Xiuyan Wang, Kun Li	107
13	Methotrexate-loaded porous polymeric adsorbents as oral sustained release formulations 2017 ·Materials Science and Engineering C ·Xiuyan Wang, Husheng Yan	14
14	In Silico Analysis of Epitope-Based Vaccine Candidates against Hepatitis B Virus Polymerase Protein 2017 ·Viruses ·(unknown), (unknown), Xiuyan Wang, Liyu Zheng, (unknown), (unknown), (unknown), (unknown)	48
15	Impact of HBeAg on the maturation and function of dendritic cells 2016 ·International Journal of Infectious Diseases ·(unknown), (unknown), Xiuyan Wang, Jin‐Ming Wu, (unknown), Wenzhi Wu, Zhiming Huang	15
16	Large-scale Clinical-grade Retroviral Vector Production in a Fixed-Bed Bioreactor 2015 ·Journal of Immunotherapy ·Xiuyan Wang, Malgorzata Olszewska, Jinrong Qu, Teresa Wasielewska, Shirley Bartido, (unknown), Michel Sadelain, Isabelle Rivière	53
17	[Study of timing of invasive and noninvasive sequential ventilation in patients with acute respiratory distress syndrome]. 2014 ·PubMed ·Xiuyan Wang, (unknown), Guangming Liu, (unknown)	5
18	How do CARs work? 2012 ·OncoImmunology ·Marco L. Davila, Renier J. Brentjens, Xiuyan Wang, Isabelle Rivière, Michel Sadelain	77
19	Molecular Remission and B Cell Aplasia Induced in a First Cohort of Adults with Relapsed B-ALL Treated with 19–28z CAR-Targeted T Cells 2012 ·Blood ·Marco L. Davila, Isabelle Rivière, Xiuyan Wang, Jae H. Park, Jolanta Stefanski, Clare Taylor, Qing He, Malgorzata Olszewska, Teresa Wasielewska, Oriana Bórquez-Ojeda, Jinrong Qu, Shirley Bartido, Joseph G. Jurcic, Dan Douer, Mark G. Frattini, Michel Sadelain, Renier J. Brentjens	1
20	The N- and C-Terminal Domains of the NS1 Protein of Influenza B Virus Can Independently Inhibit IRF-3 and Beta Interferon Promoter Activation 2004 ·Journal of Virology ·(unknown), Bianca Dauber, Xiuyan Wang, Christopher F. Basler, Thorsten Wolff, Adolfo Garcı́a-Sastre	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact